About this trial
To identify the risk factors associated with bacterial colonization of Double-J ureteral stents and to evaluate its clinical implications, including bacteriuria, UTI, antimicrobial resistance, and stent-related symptoms.
Eligibility criteria
Qualifiers
Patients undergoing temporary Double-J ureteral stent insertion.
Stent inserted for a standard urological indication, including ureteric stone disease, ureteral obstruction, postoperative drainage, or ureteral injury repair.
Planned stent removal during the study follow-up period.
Availability for clinical follow-up and specimen collection at insertion and removal.
Disqualifiers
Active urosepsis at the time of stent insertion.
Permanent or intended long-term stenting outside the study framework.
Concomitant nephrostomy tube or urinary diversion that may confound microbiological results.
Known severe immunosuppression or neutropenia if expected to substantially alter colonization risk.
Trial design
Treatments tested in this trial
- Urine and stent cultures